Omada Health Q2 Revenue Surges 43% as Company Reaches Positive EBITDA
Key Facts
Amid the ongoing expansion of the digital healthcare sector, Omada Health announced strong financial results for the second quarter of 2026. According to reports, the company recorded a significant 43% revenue growth, successfully achieving positive adjusted EBITDA. This performance marks a critical shift in the company's financial trajectory alongside meaningful margin expansion.
The robust growth is attributed to higher revenue per member driven by multi-program adoption, particularly in diabetes and hypertension segments. Furthermore, strategic partnerships with health plans and Pharmacy Benefit Managers (PBMs) helped lower customer acquisition costs and improve overall unit economics. These results strengthen the company's position within the evolving health-tech market.
Looking ahead, investors are monitoring the sustainability of this momentum, though numeric price levels for OMDA were unavailable at the time of this report on August 12, 2026. From a macro perspective, market participants should consider the recent US labor data, including the unemployment rate reported on August 7, 2026, as employment conditions directly impact health plan coverage and demand for digital care services.